Gao-jun Teng

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

1 in Phase 3

Quick facts

Phase 3 pipeline

Dicycloplatin (TP21) · Oncology
Dicycloplatin is a platinum-based chemotherapy agent that forms DNA crosslinks to inhibit cancer cell proliferation.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Gao-jun Teng portfolio CI brief
Gao-jun Teng pipeline updates RSS

Frequently asked questions about Gao-jun Teng

What is Gao-jun Teng's pipeline?

Gao-jun Teng has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Dicycloplatin (TP21).

Sector hub: All tracked pharma companies